Internal Medicine, Clinical Cardiatric Electrophysiology · Cary, NC
NPI
1609874130
Since 2005
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Ashville Ave, 301
Cary, NC, 27518
Phone (919) 851-6901
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
5,830 services
Medicare patients, 2024
1,589
Average age 77
Drug cost, 2024
$1.2M
5,141 prescriptions
Company payments, 2025
$186
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sameh K Mobarek was code 93296 (external electrocardiographic monitoring), 924 times for 338 patients. In total Sameh K Mobarek billed 5,830 services in 101 codes, and Medicare paid $285K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 924 | 338 | $14.28 | $13K |
| 93294 External Electrocardiographic Monitoring | Office | 653 | 238 | $20.29 | $13K |
| 93010 Electrocardiogram | Facility | 567 | 409 | $5.34 | $3,028 |
| 93298 External Electrocardiographic Monitoring | Office | 333 | 50 | $71.63 | $24K |
| 93295 External Electrocardiographic Monitoring | Office | 279 | 104 | $24.78 | $6,912 |
| 99214 Office E&M - Established | Office | 260 | 217 | $85.50 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 258 | 95 | $87.35 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 222 | 107 | $58.14 | $13K |
| 93000 Electrocardiogram | Office | 215 | 189 | $9.11 | $1,958 |
| 99213 Office E&M - Established | Office | 184 | 165 | $53.46 | $9,837 |
| 93306 Echocardiography (TTE/TEE) | Facility | 178 | 178 | $48.04 | $8,551 |
| 93306 Echocardiography (TTE/TEE) | Office | 172 | 166 | $127.60 | $22K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 156 | 39 | $4.43 | $691 |
| 93793 Care Management/Coordination | Office | 101 | 52 | $7.05 | $712 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 92 | 46 | $84.90 | $7,810 |
By year: 2022 $354K for 7,813 services; 2023 $338K for 7,445 services; 2024 $285K for 5,830 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 82 | 40 | $4.20 | $344 |
Medicare prescription drug claims, 2024
In 2024, the drug Sameh K Mobarek prescribed most often to Medicare patients was Eliquis (Apixaban), with 581 prescriptions and refills. In total Sameh K Mobarek wrote 5,141 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 581 | 1,001 | 126 | $569K |
| Metoprolol Succinate Generic | 257 | 666 | 91 | $3,801 |
| Flecainide Acetate Generic | 233 | 602 | 71 | $11K |
| Xarelto Rivaroxaban | 178 | 364 | 42 | $198K |
| Carvedilol Generic | 166 | 440 | 44 | $1,883 |
| Sodium Chloride 0.9 % Sodium Chloride | 153 | 153 | Under 11 | $6,253 |
| Dofetilide Generic | 143 | 314 | 34 | $29K |
| Midodrine Hcl Generic | 143 | 249 | 51 | $11K |
| Losartan Potassium Generic | 142 | 375 | 51 | $1,657 |
| Amlodipine Besylate Generic | 137 | 320 | 37 | $1,031 |
| Entresto Sacubitril/Valsartan | 131 | 189 | 25 | $124K |
| Atorvastatin Calcium Generic | 127 | 341 | 40 | $1,641 |
| Droxidopa Generic | 123 | 123 | 16 | $31K |
| Furosemide Generic | 116 | 285 | 38 | $644 |
| Metoprolol Tartrate Generic | 114 | 210 | 29 | $410 |
Brand drugs: - claims; generic drugs: 3,795 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sameh K Mobarek $186 ($186 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abiomed with $92.86.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.